Major advances in the treatment of lung cancer, specifically targeted therapies and immunotherapies, have demonstrated a survival benefit in clinical trials. To measure the effects of these advances at the population level, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, conducted an analysis of the US Surveillance, Epidemiology, and […]

Precision oncology computational methods for diagnosis and treatment selection are generating increased attention in parallel with the increased use of targeted cancer therapies. To outline best practices for ensuring the clinical utility of predictive computational methods in the oncology clinic, the National Cancer Policy Forum and the Board on Mathematical Sciences and Analytics at the […]

COVID-19 has forced many organizations to make a rapid shift to virtual meetings; this transition has been a challenge for many pharma and medical companies. There’s no doubt that in-person outreach has unique advantages, but virtual meetings have become the default plan for the foreseeable future. If your organization has struggled to adjust, it’s time […]

Key opinion leaders (KOLs) play a vital role in pharma and biotech companies. The most successful organizations rely on regular feedback from qualified experts. Incorporating feedback into your business strategy gives your company an edge. Expert guidance helps your organization reach its goals and avoid costly pitfalls. Still, forging connections with renowned clinical experts isn’t […]